ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,701.70
0.96%
S&P ASX All Technology
3,075.00
0.84%
Brent Oil
81.295
0.00%
US Dollar vs AUD
1.49858
0.00%
Bitcoin
67,901.23
0.27%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Veracyte Inc (VCYT)

  7. Veracyte Inc (VCYT) News

VCYT

Veracyte (VCYT)

Veracyte Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:VCYT
DateTimeSourceHeadlineSymbolCompany
31/05/202406:41Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VCYTVeracyte Inc
29/05/202406:26Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:VCYTVeracyte Inc
23/05/202406:05Business WireVeracyte Announces Multiple Afirma GRID Presentations at ENDO 2024, Previewing the Future of Molecular Testing in Thyroid Nodules and CancerNASDAQ:VCYTVeracyte Inc
16/05/202407:04Business WireVeracyte to Participate in Upcoming Investor ConferencesNASDAQ:VCYTVeracyte Inc
09/05/202407:03Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:VCYTVeracyte Inc
08/05/202406:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VCYTVeracyte Inc
08/05/202406:05Business WireVeracyte Announces First Quarter 2024 Financial ResultsNASDAQ:VCYTVeracyte Inc
07/05/202406:05Business Wire14 Studies Presented at AUA 2024 Show Decipher Tests’ Ability to Help Personalize Care for Prostate and Bladder Cancer Patients and Advance Disease UnderstandingNASDAQ:VCYTVeracyte Inc
23/04/202407:00Business WireVeracyte to Release First Quarter 2024 Financial Results on May 7, 2024NASDAQ:VCYTVeracyte Inc
22/04/202422:30Business WireNew Study Shows Veracyte’s Decipher Prostate Test is Prognostic for Prostate Cancer Progression Among Patients Undergoing Active SurveillanceNASDAQ:VCYTVeracyte Inc
16/04/202422:30Business WireVeracyte Announces that Nine Studies Reinforcing the Value of Decipher Prostate and Decipher Bladder Testing Will Be Presented at AUA 2024NASDAQ:VCYTVeracyte Inc
09/03/202408:37Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VCYTVeracyte Inc
09/03/202408:37Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VCYTVeracyte Inc
09/03/202408:37Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VCYTVeracyte Inc
09/03/202408:36Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VCYTVeracyte Inc
09/03/202408:36Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VCYTVeracyte Inc
09/03/202408:36Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VCYTVeracyte Inc
06/03/202409:29Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VCYTVeracyte Inc
06/03/202409:29Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VCYTVeracyte Inc
06/03/202409:28Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VCYTVeracyte Inc
06/03/202409:27Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VCYTVeracyte Inc
06/03/202409:27Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VCYTVeracyte Inc
01/03/202409:27Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VCYTVeracyte Inc
01/03/202409:22Edgar (US Regulatory)Form 424B7 - Prospectus [Rule 424(b)(7)]NASDAQ:VCYTVeracyte Inc
01/03/202409:20Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:VCYTVeracyte Inc
01/03/202408:40Edgar (US Regulatory)Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuersNASDAQ:VCYTVeracyte Inc
01/03/202400:06Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:VCYTVeracyte Inc
28/02/202409:55Business WireVeracyte’s Decipher Prostate Test Receives Highest Evidence-Level Rating Among Molecular Tests in Updated Prostate Cancer NCCN GuidelinesNASDAQ:VCYTVeracyte Inc
23/02/202408:12Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VCYTVeracyte Inc
23/02/202408:05Business WireVeracyte Announces Fourth Quarter and Full-Year 2023 Financial ResultsNASDAQ:VCYTVeracyte Inc
 Showing the most relevant articles for your search:NASDAQ:VCYT

Your Recent History

NYSE
TPVZ
LSE
CNEU
Am Msci C Esg
NASDAQ
CTXR
Citius Pharmaceuticals
TSXV
ZOX
USOTC
CAPFF
Capital (QX)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved